LEFLUNOMIDE SZ leflunomide 100mg tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

leflunomide, Quantity: 100 mg

Disponible des:

Southern Cross Pharma Pty Ltd

Designació comuna internacional (DCI):

Leflunomide

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000

Vía de administración:

Oral

Unidades en paquete:

3 tablet

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Treatment of active rheumatoid arthritis. The combined use of leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Resumen del producto:

Visual Identification: White, oblong biconvex tablets with a scoreline on one side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-04-02